Description

Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis.

Figure 5

Diagram

Source Paper

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37631065

DOI: 10.3390/ph16081150

Cite This Figure

![Figure 5: Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis." />
  <figcaption>Figure 5. Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>

Related Evidence

Curcumin for Ulcerative Colitis (UC)

Grade B · 5 studies

N-Acetyl Cysteine (NAC) for Inflammatory Bowel Disease (IBD) — General

Grade D · 1 studies